Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study

Authors

Lei Zhao (ORCID: https://orcid.org/0000-0003-1263-1742)
Xiujuan Qu (ORCID: https://orcid.org/0009-0005-9366-2314)
Yunpeng Liu (ORCID: https://orcid.org/0000-0002-9645-7990)
Man Li (ORCID: https://orcid.org/0000-0001-9365-297X)
Yu Jiang (ORCID: https://orcid.org/0000-0001-7344-7274)
Ying Luo (ORCID: https://orcid.org/0000-0001-9834-9419)
Ying Wang (ORCID: https://orcid.org/0000-0003-2377-9101)
Ping Yu (ORCID: https://orcid.org/0000-0002-9753-2438)
Yanqiao Zhang (ORCID: https://orcid.org/0000-0002-6206-8364)
Zhenghua Wang (ORCID: https://orcid.org/0000-0002-1073-8055)
Yuee Teng (ORCID: https://orcid.org/0000-0002-9198-9795)
Hao Chen (ORCID: https://orcid.org/0000-0002-7509-5820)
Zan Teng (ORCID: https://orcid.org/0000-0001-9095-696X)
Lingyun Zhang (ORCID: https://orcid.org/0000-0002-6497-1696)
Ying Chen (ORCID: https://orcid.org/0000-0002-8884-3138)
Jian Zhang (ORCID: https://orcid.org/0000-0001-7217-0111)
Jing Shi (ORCID: https://orcid.org/0000-0002-5302-5653)
Huijuan Zhang (ORCID: https://orcid.org/0000-0002-9008-2809)
Jingdong Zhang (ORCID: https://orcid.org/0000-0002-0711-2764)
Jinglei Qu
Bo Jin (ORCID: https://orcid.org/0000-0003-2000-5119)
Jiwei Liu (ORCID: https://orcid.org/0000-0001-5040-6242)
Yu Cheng (ORCID: https://orcid.org/0000-0001-5528-2058)
Chang Wang (ORCID: https://orcid.org/0000-0003-1435-0143)
Jiawen Xiao (ORCID: https://orcid.org/0000-0002-8359-7484)
Zhendong Zheng (ORCID: https://orcid.org/0000-0002-6486-3062)
Sa Liu (ORCID: https://orcid.org/0000-0003-1724-7870)